Skip to main content

Table 1 Determining the cumulative dose of ferric(III)carboxymaltose

From: Multicentre randomized controlled trial comparing ferric(III)carboxymaltose infusion with oral iron supplementation in the treatment of preoperative anaemia in colorectal cancer patients

Hb mmol/L (g/dl) Patients weight: 35–70 kg Patients weight: > 70 kg
<6.2 mmol/L (10 g/dl) 1500 mg 2000 mg
>6.2 mmol/L (10 g/dl) 1000 mg 1500 mg
  1. N.B: The maximum dose administered per week is 1000 mg. The maximum dose administered per patient may not exceed 15 mg/kg. Therefore, for patients with a weight under 67 Kg, all calculated doses should be given in two infusions (as 1000/15 = 66.7)